Clinical Edge Journal Scan

Obesity is linked to high-risk prostate cancer in multiethnic population


 

Key clinical point: Obesity (body mass index of ≥30 kg/m 2) is associated with high-risk prostate cancer in non-Hispanic Black (NHB) and Hispanic men.

Major finding: Obesity showed an independent association with high-risk prostate cancer (odds ratio [OR] 2.23; 95% CI 1.28-3.81). Compared with nonobese men without diabetes mellitus (DM), those with obesity and DM showed a higher risk for intermediate- (OR 1.93; P = .013) and high-risk prostate cancer (OR 2.40; P = .011).

Study details: This was a retrospective study of 1,303 patients with prostate cancer. The prevalence of obesity and DM was 29.3% and 28.3%, respectively. Most of the patients were of NHB (38%) or Hispanic ethnicity (31%).

Disclosures: This work was funded by the American Cancer Society. The authors declared no conflicts of interest.

Source: Zhu D et al. Clin Genitourin Cancer. 2022 (Jan 31). Doi: 10.1016/j.clgc.2022.01.016.

Recommended Reading

Localized prostate cancer: Temporary decline in HRQoL with docetaxel
Federal Practitioner
A 3-tier prostate cancer screening is feasible
Federal Practitioner
Family history of prostate or breast cancer is linked with high-grade prostate cancer
Federal Practitioner
Prostate cancer: Higher depression risk with second-generation antiandrogens
Federal Practitioner
Clinical Edge Journal Scan Commentary: Prostate Cancer February 2022
Federal Practitioner
Metastatic CRPC: Autologous dendritic cell-based immunotherapy fails to extend survival
Federal Practitioner
Niraparib shows activity in mCRPC
Federal Practitioner
Localized prostate cancer: Add-on ADT delays metastasis
Federal Practitioner
Prostate cancer: Salvage radiotherapy after surgery extends long-term survival
Federal Practitioner
Prostate cancer: Active surveillance may be appropriate in selected intermediate-risk patients
Federal Practitioner